Drachman David J 4
4 · AtriCure, Inc. · Filed Sep 13, 2012
Insider Transaction Report
Form 4
AtriCure, Inc.ATRC
Drachman David J
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2012-09-12$7.04/sh−20,000$140,800→ 146,000 total - Exercise/Conversion
Common Stock
2012-09-12$5.60/sh+20,000$111,950→ 166,000 total - Exercise/Conversion
Stock Option (right to buy)
2012-09-12−20,000→ 90,000 totalExercise: $5.60From: 2011-02-12Exp: 2020-02-12→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $7.03 to $7.11 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]These options were granted on February 12, 2010 and are exercisable as to 25% of the shares on February 12, 2011 (one year from the date of grant) and the remaining 75% thereafter vesting and exercisable in equal monthly installments on the same day of the month over the following three years.